A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...
A mitochondrial enzyme, Ak4, strengthens immune defense by promoting mitochondrial DNA synthesis and enhancing macrophage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results